Loading ...
Loading ...
9. Aug 24
7. Aug 24
7. Aug 24
6. Aug 24
6. Aug 24
On February 1st, after Ardelyx spent $340k lobbying Congress on issues related to Medicare ESRD benefits & chronic kidney disease management, our Lobbying Spending Growth Strategy went long on $ARDX. The stock has soared nearly 55% since.
8. Aug 24
8. Aug 24
6. Aug 24
2. Aug 24
31. Jul 24